January 01st, 2024

On Friday, January 5, an array of companies is set to disclose their financial results, including: Constellation Brands, Inc. (NYSE: STZ), a prominent beverage alcohol company, will report financial results for its third quarter fiscal 2024 before. Read more

November 18th, 2023

On Tuesday, November 21, several companies are set to report their financial results, including: NVIDIA Corporation (Nasdaq: NVDA), a global technology leader in graphics processing units (GPUs) and AI, is scheduled to release its financial result. Read more

November 05th, 2023

On Tuesday, November 7, several companies are set to report their financial results, including: D.R. Horton, Inc. (NYSE: DHI), a prominent home construction company, will unveil its financial results for the fourth quarter and fiscal year 2023 bef. Read more

October 19th, 2023

Knight-Swift Transportation Holdings Inc. (NYSE: KNX), a major transportation and trucking company, posted third-quarter 2023 earnings of $0.41 per share, surpassing the consensus EPS estimate of $0.36. The company's quarterly revenues amounted to $2. Read more

October 05th, 2023

AirSculpt Technologies, Inc. (Nasdaq: AIRS), a medical technology company specializing in body contouring procedures, has provided a positive outlook for its third-quarter 2023 revenue, with expectations set at approximately $46.5 million, surpassing. Read more

September 30th, 2023

Some of the companies expected to report financial results on Wednesday, October 4, are: Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the mar. Read more

September 26th, 2023

Shares of Profound Medical Corp. (Nasdaq: PROF) surged by more than 10% in after-hours trading after it announced FDA clearance for its Thermal Boost module in conjunction with TULSA-PRO, which allows surgeons to treat various prostate conditions, in. Read more

September 05th, 2023

America's Car-Mart, Inc. (Nasdaq: CRMT), an automotive retail company, posted first-quarter fiscal 2024 earnings of $0.63 per share, falling short of the consensus EPS estimate of $0.98. Quarterly sales for the company reached $368.00 million, slight. Read more

August 19th, 2023

A variety of companies are preparing to unveil their financial results on Tuesday, August 22, including: Lowe's Companies, Inc. (NYSE: LOW), a prominent player in the home improvement sector, is set to release its second-quarter 2023 earnings resu. Read more

August 10th, 2023

Holley Inc. (NYSE: HLLY), a leading manufacturer of high-performance automotive components, reported second-quarter 2023 earnings of $0.14 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales reached $175.26 millio. Read more

August 07th, 2023

Sohu.com Limited (Nasdaq: SOHU) revealed its unaudited second quarter 2023 financial results, reporting a total revenue of $152 million, down 22% year-over-year and 6% sequentially.  The company reported a Non-GAAP net loss of $18 million, tr. Read more

July 25th, 2023

Logitech International S.A. (Nasdaq: LOGI) announced its first-quarter fiscal 2024 results, with earnings per share (EPS) of $0.65 and revenue of $974.5 million, surpassing the consensus estimate of $0.46 on revenue of $919.69 million. Following t. Read more

July 13th, 2023

Silver Spring, MD / CRWE PRESS RELEASE / July 13, 2023 -  Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for us. Read more

July 09th, 2023

On Wednesday, July 12, several companies are expected to report their financial results, including: MillerKnoll, Inc. (Nasdaq: MLKN), a consumer goods company, is set to release its financial results for the fourth quarter and full-year fiscal 202. Read more

July 06th, 2023

Action Follows Confirmatory Trial to Verify Clinical Benefit Silver Spring, MD / CRWE PRESS RELEASE / July 06, 2023 -   Today, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult p. Read more